Tenon Medical (TNON) Return on Capital Employed (2022 - 2026)

Tenon Medical's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 282.09% for Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 13419.0% year-over-year to 282.09% in Q1 2026; TTM through Mar 2026 was 282.09%, a 13419.0% decrease from a year earlier, with the FY2025 full-year figure at 180.46%, up 4068.0% from the prior year.
• Return on Capital Employed fell to 282.09% in Q1 2026 per TNON's latest filing, from 174.04% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 116.09% in Q1 2022 and bottomed at 1087.31% in Q2 2023.
• The 5-year median for Return on Capital Employed is 178.62% (2022), against an average of 260.22%.
• Across the five-year window, Return on Capital Employed tumbled 97009 bps in 2023 and surged 70235 bps in 2024, its largest moves.
• Year by year, Return on Capital Employed stood at 178.62% in 2022, then sank by 139 bps to 426.03% in 2023, then soared by 66 bps to 143.82% in 2024, then declined by 21 bps to 174.04% in 2025, then sank by 62 bps to 282.09% in 2026.
• Per Business Quant, the three latest TNON Return on Capital Employed figures stand at 282.09% (Q1 2026), 174.04% (Q4 2025), and 170.14% (Q3 2025).